ArticleFrontiers in oncology2020

Unusual Late Relapse of ALK-Positive Anaplastic Large Cell Lymphoma Successfully Cleared Using the ALK-Inhibitor Crizotinib: Case Report.

Dennis Christoph Harrer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.